A proposed ethics overhaul tests the boundaries of European defense financing.
OSLO
Norway is considering a significant change to the investment rules governing its sovereign wealth fund, potentially allowing more than €2 trillion in state-managed assets to be invested in Western companies involved in nuclear weapons production. The proposal reflects growing tensions between longstanding ethical restrictions and Europe’s evolving security priorities.
A government-appointed commission chaired by former central bank governor Svein Gjedrem recommended relaxing restrictions that currently prevent the world’s largest sovereign wealth fund from investing in 14 companies associated with nuclear weapons development or manufacturing.
The exclusions include major aerospace and defense corporations such as Airbus, Boeing, BAE Systems, Lockheed Martin and Safran. Under the proposed framework, investments could become permissible when companies are based in nuclear-armed states recognized under the Nuclear Non-Proliferation Treaty that are also NATO allies of Norway.
The distinction would primarily benefit eligible manufacturers based in the United States, France and the United Kingdom. Companies outside that framework would remain subject to existing restrictions.
Norwegian Finance Minister Jens Stoltenberg, a former NATO secretary general, acknowledged the strategic contradiction of excluding businesses considered important to Norway’s national defense. His remarks come amid heightened European security concerns involving Russia’s nuclear threats and China’s expanding military capabilities.
The proposed changes extend beyond the defense industry. The commission also recommended restructuring the independent Council on Ethics, which evaluates whether corporate activities conflict with the fund’s investment standards.
Under the revised arrangement, the council would continue assessing potential ethical violations but would lose its authority to recommend corporate exclusions directly. Greater responsibility would shift toward Norway’s central bank, which manages the investment portfolio.
Human rights organizations have raised concerns about weakening independent oversight. Amnesty International warned that the changes could reduce transparency and undermine safeguards designed to prevent public capital from supporting companies associated with serious human rights violations.
Supporters of the review emphasize the importance of maintaining investment flexibility and recognizing the strategic role of allied defense industries. Critics argue that national security considerations should not determine whether involvement in nuclear weapons production meets established ethical standards.
The controversy illustrates a broader transformation in European financial thinking. Defense companies increasingly occupy a strategic position in discussions about industrial resilience, military preparedness and the continent’s reliance on American security capabilities.
Norway’s fund invests in more than 7,000 companies worldwide and owns approximately 1.5% of globally listed equities. Changes to its investment framework could therefore have implications beyond the Norwegian economy, influencing institutional debates about responsible investment and defense financing.
However, the recommendations do not represent an approved policy change. Public consultation will continue until January 15, 2027, with the government expected to present its assessment to Parliament the following spring.
The outcome will determine whether Norway maintains its longstanding separation between sovereign investment and nuclear weapons production or introduces a more selective framework based on strategic alliances.
Beyond the immediate financial implications, the debate raises a fundamental question about the future of responsible investment: whether ethical restrictions should remain universal or adapt to changing geopolitical and national security priorities.
Where Facts Meet Perspective.